2023 — Present
Co-Founder & Chief Executive Officer
WriteWise
Leads a pharmacy benefits company that guarantees pharmacy cost outcomes for employers, combining data intelligence, insurance precision, and its MavRx technology platform.

Board Advisors
Board Advisor
Newton Centre, Massachusetts
Dr. Hari Sundram is a Board Advisor to Valore Health and Co-Founder and Chief Executive Officer of WriteWise, a pharmacy benefits company bringing transparency and guaranteed cost certainty to employers through its MavRx platform. A physician and serial entrepreneur, he has founded companies that collectively raised more than $800 million and created over $6 billion in enterprise value, including Auris Surgical Robotics (acquired by Johnson & Johnson), Predilytics (acquired by Welltok), and Verikai (acquired by American Financial Group). He previously founded and led Radion Insurance, a level-funded carrier for the small and mid-size group market, and serves as Chairman of the Board at Anagram, a consumer claiming platform for out-of-network benefits. Trained as an anesthesiologist and pain medicine physician, he is an active early-stage investor and mentor in data-driven healthcare.
View LinkedInFocus areas
Education
Experience
2023 — Present
WriteWise
Leads a pharmacy benefits company that guarantees pharmacy cost outcomes for employers, combining data intelligence, insurance precision, and its MavRx technology platform.
2022 — 2025
Radion Insurance
Founded and led a level-funded carrier providing an affordable alternative to fully insured offerings in the small and mid-size group market.
2017 — 2021
Verikai
Built an applied data company using machine learning informed modeling for the insurance and financial services market; acquired by American Financial Group.
2012 — 2015
Predilytics
Created consumer data and analytics tools to help insurers manage at-risk lives; acquired by Welltok in 2015.
2009 — 2014
Auris Health (Auris Surgical Robotics)
Co-founded the surgical robotics company with Fred Moll, revolutionizing outpatient surgical intervention; acquired by Johnson & Johnson in 2019.
Earlier career
Tufts Medical Center
Served as assistant professor of anesthesia and pain medicine following residency at the University of Pennsylvania and fellowship at Massachusetts General Hospital.